Success Story

Ochre Bio

Gold Track worked with Ochre Bio at the early stages of their development supporting them in refining their technology-market fit, identifying clinical need, refining worldwide product strategy, investor introductions, and storytelling. In October 2022, Ochre Bio raised $30 million in their Series A funding round to develop RNA therapies for chronic liver diseases.

Founders Jack O'Meara and Quin Wills at a workshop.
all success stories
Ochre Bio Logo

4 months

In Gold Track


Year of Phase Out

More Success Stories